Alina Valimukhametova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Alina Valimukhametova has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Anton V. Naumov
Texas Christian University
8 shared publications- Ugur Can Topkiran
Texas Christian University
6 shared publications - Anton V. Naumov
Department of Physics and Astronomy Texas Christian University TCU Box 298840 Fort Worth TX 76129 USA
5 shared publications Abby Dorsky
Department of Physics and Astronomy Texas Christian University TCU Box 298840 Fort Worth TX 76129 USA
4 shared publicationsOlivia Sottile
Department of Physics and Astronomy Texas Christian University TCU Box 298840 Fort Worth TX 76129 USA
4 shared publications- Bong Lee
Department of Physics and Astronomy, Texas Christian University, Fort Worth, TX 76129, USA
3 shared publications
Latest Publications
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (9) , 764
Holistic Assessment of (6,5) Comocat Single-Walled Carbon Nanotubes as Multiplex Imaging Probes in vivo
Semiconducting single-walled carbon nanotubes (SWCNTs) are emerging as powerful near-infrared probes for deep-tissue imaging. While SWCNT samples involving multiple chiralities can be seen as a collection of spectrally-resolved fluorophores, their multiplex imaging capabilities remain underexplored. Here we present chirality-resolved evaluation of DSPE-mPEG coated CoMoCAT SWCNTs integrating optical characterization, biodistribution, pharmacokinetics, and toxicity studies in BALB/c mice. Narrow band-pass filters centered at 1000, 1050, and 1100 nm are used to isolate emission from the dominant (6,5) species and coexisting (7,5) and (7,6) chiralities within the NIR-II window. Following intraperitoneal administration, longitudinal whole-body imaging (0.5-24 h) illustrate rapid systemic spread and preferential uptake in reticuloendothelial organs. Ex vivo organ analysis reveals a hierarchy of emission intensities (liver ≫ spleen ≈ kidney ≫ lung ≈ heart) that is preserved across all three detection channels suggesting a negligible influence of SWCNT chirality on biodistribution. Serum kinetics show monoexponential decay with an apparent elimination half-life ~ 0.93 h and no significant sex-dependent differences. In a 21-day toxicity study, treated animals maintain stable body mass and normal behavior, organ-level fluorescence returns to baseline, and H&E sections of liver, kidney and lung reveal preserved architecture without inflammatory or fibrotic lesions. Collectively, this work defines safe dosing and imaging conditions for DSPE-mPEG/CoMoCAT SWCNTs and demonstrates that chirality-specific NIR-II fluorescence can be exploited for multiplex tracking of nanotube probes in vivo, providing a foundation for future biosensing and image-guided therapeutic applications.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (9) , 764
Holistic Assessment of (6,5) Comocat Single-Walled Carbon Nanotubes as Multiplex Imaging Probes in vivo
Semiconducting single-walled carbon nanotubes (SWCNTs) are emerging as powerful near-infrared probes for deep-tissue imaging. While SWCNT samples involving multiple chiralities can be seen as a collection of spectrally-resolved fluorophores, their multiplex imaging capabilities remain underexplored. Here we present chirality-resolved evaluation of DSPE-mPEG coated CoMoCAT SWCNTs integrating optical characterization, biodistribution, pharmacokinetics, and toxicity studies in BALB/c mice. Narrow band-pass filters centered at 1000, 1050, and 1100 nm are used to isolate emission from the dominant (6,5) species and coexisting (7,5) and (7,6) chiralities within the NIR-II window. Following intraperitoneal administration, longitudinal whole-body imaging (0.5-24 h) illustrate rapid systemic spread and preferential uptake in reticuloendothelial organs. Ex vivo organ analysis reveals a hierarchy of emission intensities (liver ≫ spleen ≈ kidney ≫ lung ≈ heart) that is preserved across all three detection channels suggesting a negligible influence of SWCNT chirality on biodistribution. Serum kinetics show monoexponential decay with an apparent elimination half-life ~ 0.93 h and no significant sex-dependent differences. In a 21-day toxicity study, treated animals maintain stable body mass and normal behavior, organ-level fluorescence returns to baseline, and H&E sections of liver, kidney and lung reveal preserved architecture without inflammatory or fibrotic lesions. Collectively, this work defines safe dosing and imaging conditions for DSPE-mPEG/CoMoCAT SWCNTs and demonstrates that chirality-specific NIR-II fluorescence can be exploited for multiplex tracking of nanotube probes in vivo, providing a foundation for future biosensing and image-guided therapeutic applications.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (9) , 775
Precursor-Dependent Optical and Structural Properties of Eleven NIR-Emissive Graphene Quantum Dots for Bioimaging Applications
Graphene quantum dots (GQDs) have attracted interest in the bioimaging community due to their biocompatibility and ability to emit near-infrared (NIR) fluorescence suitable for imaging and tracking in biological systems. Creating a simple, reproducible synthesis method for biocompatible NIR-fluorescent GQDs from a variety of precursors remains a critical task. The development of multiple NIR fluorescent GQD structures from a variety of precursors can facilitate their application in multiplex imaging, multianalyte sensing, and combination therapy delivery. Herein, we demonstrate the synthesis of 11 distinct GQD structures capable of NIR fluorescence, achieved through a facile microwave-assisted bottom-up carbonization of 11 different materials: ascorbic acid, chitosan, citric acid - urea, dextran, glucose, glucosamine hydrochloride, hyaluronic acid, l-glutamic acid, polyethylene glycol (PEG), sodium cholate, or sodium citrate. All GQD structures exhibit substantial biocompatibility at concentrations up to 2 mg/mL. Internalization of GQDs is observed via their NIR fluorescence, enabling their in vitro tracking in HEK-293 cells. This work provides a comprehensive study demonstrating how precursor selection enables versatile synthetic outcomes and NIR-emissive GQDs with distinct physical, chemical, and optical properties relevant to bioimaging. Expanding the precursor range democratizes the use of GQDs in biological applications by providing broader access to structures with tunable NIR emission and surface characteristics.
- 7 July 2026
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2026-01 (9) , 775
Precursor-Dependent Optical and Structural Properties of Eleven NIR-Emissive Graphene Quantum Dots for Bioimaging Applications
Graphene quantum dots (GQDs) have attracted interest in the bioimaging community due to their biocompatibility and ability to emit near-infrared (NIR) fluorescence suitable for imaging and tracking in biological systems. Creating a simple, reproducible synthesis method for biocompatible NIR-fluorescent GQDs from a variety of precursors remains a critical task. The development of multiple NIR fluorescent GQD structures from a variety of precursors can facilitate their application in multiplex imaging, multianalyte sensing, and combination therapy delivery. Herein, we demonstrate the synthesis of 11 distinct GQD structures capable of NIR fluorescence, achieved through a facile microwave-assisted bottom-up carbonization of 11 different materials: ascorbic acid, chitosan, citric acid - urea, dextran, glucose, glucosamine hydrochloride, hyaluronic acid, l-glutamic acid, polyethylene glycol (PEG), sodium cholate, or sodium citrate. All GQD structures exhibit substantial biocompatibility at concentrations up to 2 mg/mL. Internalization of GQDs is observed via their NIR fluorescence, enabling their in vitro tracking in HEK-293 cells. This work provides a comprehensive study demonstrating how precursor selection enables versatile synthetic outcomes and NIR-emissive GQDs with distinct physical, chemical, and optical properties relevant to bioimaging. Expanding the precursor range democratizes the use of GQDs in biological applications by providing broader access to structures with tunable NIR emission and surface characteristics.
- 11 July 2025
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2025-01 (11) , 913
(Invited) Biodistribution, Pharmacokinetics and Toxicology of Graphene Quantum Dots – an in vivo Study
Graphene quantum dots (GQDs) serve as remarkable agents for drug and gene therapeutic delivery targeted treatment of complex diseases including cancer, sensing of biomolecules, cancer-generated genes and environmental conditions including the temperature and pH. GQDs design to emit fluorescence in the near-infrared (NIR) due to its high penetration depth are now utilized in biological imaging within subcellular and intracellular environments as well as in biological tissues and live animal models. Given their promising potential in image-guided delivery, the outlets of NIR-emissive GQDs in live targets need to be explored to further focus and enhance their applications in vivo. In the present work we explore GQD in vivo toxicity (describing maximum amounts that could be used for delivery and imaging), biodistribution (showing the tissues that can be targeted by the GQDs and the regions within particular animal tissues that acquire maximum GQD accumulation) and pharmacokinetics (showing GQD circulation times in blood that could help identify relevant clinical targets). In this study GQD content is analyzed vi a NIR fluorescence imaging allowing for semi-quantitative assessment through the layers of biological tissue. When injected intravenously (IV) or intraperitonially (IP) into live BALB/c mice GQDs distribute into multiple murine organs with maximum fluorescence intensity in liver, kidneys spleen, heart, spleen, thymus, brain and joints with most of the organs experiencing maximum accumulations at 6 – 24 h time points. During first pass metabolism we expect GRDs to partially clear through liver and kidneys. Kidneys expectedly experience faster (~1 h) clearance of the GQDs than liver (6 – 12 h) with the prolonged residence time noted for spleen (12 – 24 h). While the bulk fluorescence signal provides semi-quantitative accumulation information, the location of the GQDs within the tissue in the cells is further studied in animal organ slice microscopy that explores the possibility of GQDs entering such complex targets as brain. While accumulation in the majority of the aforementioned organ targets is expected from metabolic pathways of the GQDs, their high and prominent in mouse joints with over 48 h retention times is unforeseen and can serve toward advancement of joint therapy delivery and joint imaging applications. While being amphiphilic but only nanometer-sized particles, GQDs experience appreciable blood circulation times of 3.8 h allowing for a variety of therapeutic delivery approaches including even non-targeted cancer therapeutics. Their early-stage clearance is attributed to the renal pathway, while at later time points it is expected to be dominated by the reticuloendothelial system. Toxicologically GQDs appear to be superior to a plethora of their nanomaterial counterparts with concentration up to 16.5 mg/mL showing no toxic response in mice in terms of weight and behavior for the period of 3 weeks post administration. These concentrations are surpass the ones used for imaging 10-fold. Conformational tissue changes are further analyzed using H&E-stained organ slice microscopy. This work demonstrates that GQDs have a promising potential to serve as a viable platform for therapeutic delivery and imaging in multiple organs at ultra-high non-toxic concentrations with their circulation times allowing for anticancer therapeutic delivery applications.
- 11 July 2025
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2025-01 (11) , 913
(Invited) Biodistribution, Pharmacokinetics and Toxicology of Graphene Quantum Dots – an in vivo Study
Graphene quantum dots (GQDs) serve as remarkable agents for drug and gene therapeutic delivery targeted treatment of complex diseases including cancer, sensing of biomolecules, cancer-generated genes and environmental conditions including the temperature and pH. GQDs design to emit fluorescence in the near-infrared (NIR) due to its high penetration depth are now utilized in biological imaging within subcellular and intracellular environments as well as in biological tissues and live animal models. Given their promising potential in image-guided delivery, the outlets of NIR-emissive GQDs in live targets need to be explored to further focus and enhance their applications in vivo. In the present work we explore GQD in vivo toxicity (describing maximum amounts that could be used for delivery and imaging), biodistribution (showing the tissues that can be targeted by the GQDs and the regions within particular animal tissues that acquire maximum GQD accumulation) and pharmacokinetics (showing GQD circulation times in blood that could help identify relevant clinical targets). In this study GQD content is analyzed vi a NIR fluorescence imaging allowing for semi-quantitative assessment through the layers of biological tissue. When injected intravenously (IV) or intraperitonially (IP) into live BALB/c mice GQDs distribute into multiple murine organs with maximum fluorescence intensity in liver, kidneys spleen, heart, spleen, thymus, brain and joints with most of the organs experiencing maximum accumulations at 6 – 24 h time points. During first pass metabolism we expect GRDs to partially clear through liver and kidneys. Kidneys expectedly experience faster (~1 h) clearance of the GQDs than liver (6 – 12 h) with the prolonged residence time noted for spleen (12 – 24 h). While the bulk fluorescence signal provides semi-quantitative accumulation information, the location of the GQDs within the tissue in the cells is further studied in animal organ slice microscopy that explores the possibility of GQDs entering such complex targets as brain. While accumulation in the majority of the aforementioned organ targets is expected from metabolic pathways of the GQDs, their high and prominent in mouse joints with over 48 h retention times is unforeseen and can serve toward advancement of joint therapy delivery and joint imaging applications. While being amphiphilic but only nanometer-sized particles, GQDs experience appreciable blood circulation times of 3.8 h allowing for a variety of therapeutic delivery approaches including even non-targeted cancer therapeutics. Their early-stage clearance is attributed to the renal pathway, while at later time points it is expected to be dominated by the reticuloendothelial system. Toxicologically GQDs appear to be superior to a plethora of their nanomaterial counterparts with concentration up to 16.5 mg/mL showing no toxic response in mice in terms of weight and behavior for the period of 3 weeks post administration. These concentrations are surpass the ones used for imaging 10-fold. Conformational tissue changes are further analyzed using H&E-stained organ slice microscopy. This work demonstrates that GQDs have a promising potential to serve as a viable platform for therapeutic delivery and imaging in multiple organs at ultra-high non-toxic concentrations with their circulation times allowing for anticancer therapeutic delivery applications.
- Open Access
Holistic Investigation of Graphene Quantum Dot Endocytosis
Graphene quantum dots (GQDs) have gained popularity in nano‐biotechnology due to their multifunctional delivery and imaging capabilities. The outcome of their therapeutic delivery applications relies on understanding cell internalization routes. Current literature presents often conflicting results based on surveying only a few endocytosis inhibitors. Herein, a holistic approach to cell uptake studies by utilizing six different inhibitors while considering their on‐ and off‐target effects on internalization of the GQDs of different charges is provided. Endocytosis paths are explored by tracking intracellular GQD fluorescence in HeLa or HEK‐293 cells. Contrary to the previous assumptions of a singular entry route, findings suggest that GQDs enter the cells through several endocytosis paths with some more prevalent than others. Selectivity between the pathways is based on GQD charge and functional groups. Positively charged nitrogen‐doped GQDs (NGQDs) predominantly utilize a fast endophilin‐mediated endocytosis (FEME) in HeLa cells with a secondary preference for clathrin‐mediated endocytosis (CME). In HEK‐293 cells NGQDs internalize via clathrin‐independent, glycosylphosphatidylinositol‐anchored protein‐enriched compartments (CLIC/GEEC) and FEME. Conversely, GQDs with a substantial negative surface charge uptake through CME in HeLa cells. The optimization of these mechanisms can enhance GQD applications in biomedicine, ideally streamlining their translation into the clinic.
Open AccessHolistic Investigation of Graphene Quantum Dot Endocytosis
Graphene quantum dots (GQDs) have gained popularity in nano‐biotechnology due to their multifunctional delivery and imaging capabilities. The outcome of their therapeutic delivery applications relies on understanding cell internalization routes. Current literature presents often conflicting results based on surveying only a few endocytosis inhibitors. Herein, a holistic approach to cell uptake studies by utilizing six different inhibitors while considering their on‐ and off‐target effects on internalization of the GQDs of different charges is provided. Endocytosis paths are explored by tracking intracellular GQD fluorescence in HeLa or HEK‐293 cells. Contrary to the previous assumptions of a singular entry route, findings suggest that GQDs enter the cells through several endocytosis paths with some more prevalent than others. Selectivity between the pathways is based on GQD charge and functional groups. Positively charged nitrogen‐doped GQDs (NGQDs) predominantly utilize a fast endophilin‐mediated endocytosis (FEME) in HeLa cells with a secondary preference for clathrin‐mediated endocytosis (CME). In HEK‐293 cells NGQDs internalize via clathrin‐independent, glycosylphosphatidylinositol‐anchored protein‐enriched compartments (CLIC/GEEC) and FEME. Conversely, GQDs with a substantial negative surface charge uptake through CME in HeLa cells. The optimization of these mechanisms can enhance GQD applications in biomedicine, ideally streamlining their translation into the clinic.
- 9 August 2024
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2024-01 (8) , 836
Multiplex Bioimaging with Near-Infrared Fluorescent Graphene Quantum Dots
Due to high tissue penetration depth and low autofluorescence backgrounds, near-infrared (NIR) fluorescence imaging has recently become an advantageous diagnostic technique used in a variety of fields. However, most of the NIR fluorophores do not have therapeutic delivery capabilities, exhibit low photostabilities, and raise toxicity concerns. To address these issues, we developed and tested five types of biocompatible graphene quantum dots (GQDs) exhibiting spectrally separated fluorescence in the NIR range of 928 – 1053 nm with NIR excitation. Their optical properties in the NIR are attributed to either rare-earth metal dopants (Ho-NGQDs, Yb-NGQDs, Nd-NGQDs) or defect-states (NGQDs, RGQDs) as verified by Hartree-Fock calculations. Moderate up to 1.34 % quantum yields of these GQDs are well-compensated by their remarkable >4-hour photostability. At the biocompatible concentrations of up to 0.5 – 2 mg/mL GQDs successfully internalize into HEK-293 cells and enable in vitro imaging in the visible and NIR. Tested all together in HEK-293 cells five GQD types enable simultaneous multiplex imaging in the NIR-I and NIR-II shown for the first time in this work for GQD platforms. Substantial photostability, spectrally-separated NIR emission, and high biocompatibility of five GQD types developed here suggest their promising potential in multianalyte testing and multiwavelength bioimaging of combination therapies.
- 9 August 2024
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2024-01 (8) , 836
Multiplex Bioimaging with Near-Infrared Fluorescent Graphene Quantum Dots
Due to high tissue penetration depth and low autofluorescence backgrounds, near-infrared (NIR) fluorescence imaging has recently become an advantageous diagnostic technique used in a variety of fields. However, most of the NIR fluorophores do not have therapeutic delivery capabilities, exhibit low photostabilities, and raise toxicity concerns. To address these issues, we developed and tested five types of biocompatible graphene quantum dots (GQDs) exhibiting spectrally separated fluorescence in the NIR range of 928 – 1053 nm with NIR excitation. Their optical properties in the NIR are attributed to either rare-earth metal dopants (Ho-NGQDs, Yb-NGQDs, Nd-NGQDs) or defect-states (NGQDs, RGQDs) as verified by Hartree-Fock calculations. Moderate up to 1.34 % quantum yields of these GQDs are well-compensated by their remarkable >4-hour photostability. At the biocompatible concentrations of up to 0.5 – 2 mg/mL GQDs successfully internalize into HEK-293 cells and enable in vitro imaging in the visible and NIR. Tested all together in HEK-293 cells five GQD types enable simultaneous multiplex imaging in the NIR-I and NIR-II shown for the first time in this work for GQD platforms. Substantial photostability, spectrally-separated NIR emission, and high biocompatibility of five GQD types developed here suggest their promising potential in multianalyte testing and multiwavelength bioimaging of combination therapies.
- 9 August 2024
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2024-01 (8) , 862
Endocytosis Pathways of Graphene Quantum Dots
Graphene quantum dots (GQDs) have emerged as a forerunner of carbon nanbiootechnology due to their multifunctional delivery and imaging capabilities as they exhibit fluorescence in the visible and near-infrared, high biocompatibility, and water solubility. These properties put GQDs forward as a compelling drug delivery platform that has already been utilized in a variety of applications including the delivery of chemotherapeutics, antibiotics as well as siRNA and CRISPR-based gene therapy. However, cellular entry pathways of this nanomaterial still remain largely undefined. In a number of studies describing GQD cellular internalization different and, often, conflicting results have been presented due to surveying only few endocytosis inhibitors and disregarding their potential off-target pathways. Understanding the cell internalization routes of GQDs is crucial while delivering drugs in different types of cell lines. Herein, we performed a holistic approach to cell uptake studies on GQDs of different charges by the comparative study of their preferred endocytosis paths in non-cancerous (HEK-293) and cancerous (HeLa) cell lines. The concentration and cell viability of GQDs were determined by MTT assays, while their endocytosis paths were investigated through confocal fluorescence microscopy on cells treated for up to 24 hours. The potential for GQD interactions with the cell membrane was also examined via zeta (ζ) potential measurements. Our findings provide insights into the internalization mechanisms of the GQDs into cell membranes of healthy and cancer cells. The optimization of these mechanisms can serve for the enhancement of a variety of novel GQD applications in biomedicine including therapeutic delivery, disease detection through sensing as well as diagnostic imaging.
- 9 August 2024
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2024-01 (8) , 862
Endocytosis Pathways of Graphene Quantum Dots
Graphene quantum dots (GQDs) have emerged as a forerunner of carbon nanbiootechnology due to their multifunctional delivery and imaging capabilities as they exhibit fluorescence in the visible and near-infrared, high biocompatibility, and water solubility. These properties put GQDs forward as a compelling drug delivery platform that has already been utilized in a variety of applications including the delivery of chemotherapeutics, antibiotics as well as siRNA and CRISPR-based gene therapy. However, cellular entry pathways of this nanomaterial still remain largely undefined. In a number of studies describing GQD cellular internalization different and, often, conflicting results have been presented due to surveying only few endocytosis inhibitors and disregarding their potential off-target pathways. Understanding the cell internalization routes of GQDs is crucial while delivering drugs in different types of cell lines. Herein, we performed a holistic approach to cell uptake studies on GQDs of different charges by the comparative study of their preferred endocytosis paths in non-cancerous (HEK-293) and cancerous (HeLa) cell lines. The concentration and cell viability of GQDs were determined by MTT assays, while their endocytosis paths were investigated through confocal fluorescence microscopy on cells treated for up to 24 hours. The potential for GQD interactions with the cell membrane was also examined via zeta (ζ) potential measurements. Our findings provide insights into the internalization mechanisms of the GQDs into cell membranes of healthy and cancer cells. The optimization of these mechanisms can serve for the enhancement of a variety of novel GQD applications in biomedicine including therapeutic delivery, disease detection through sensing as well as diagnostic imaging.
- Open Access
- 19 January 2024
- Published by IOP Publishing in 2D Materials
- Vol. 11 (2) , 025009
Five near-infrared-emissive graphene quantum dots for multiplex bioimaging
Due to high tissue penetration depth and low autofluorescence backgrounds, near-infrared (NIR) fluorescence imaging has recently become an advantageous diagnostic technique used in a variety of fields. However, most of the NIR fluorophores do not have therapeutic delivery capabilities, exhibit low photostabilities, and raise toxicity concerns. To address these issues, we developed and tested five types of biocompatible graphene quantum dots (GQDs) exhibiting spectrally-separated fluorescence in the NIR range of 928–1053 nm with NIR excitation. Their optical properties in the NIR are attributed to either rare-earth metal dopants (Ho-NGQDs, Yb-NGQDs, Nd-NGQDs) or defect-states (nitrogen doped GQDS (NGQDs), reduced graphene oxides) as verified by Hartree-Fock calculations. Moderate up to 1.34% quantum yields of these GQDs are well-compensated by their remarkable >4 h photostability. At the biocompatible concentrations of up to 0.5–2 mg ml−1 GQDs successfully internalize into HEK-293 cells and enable in vitro imaging in the visible and NIR. Tested all together in HEK-293 cells five GQD types enable simultaneous multiplex imaging in the NIR-I and NIR-II shown for the first time in this work for GQD platforms. Substantial photostability, spectrally-separated NIR emission, and high biocompatibility of five GQD types developed here suggest their promising potential in multianalyte testing and multiwavelength bioimaging of combination therapies.
- 19 January 2024
- Published by IOP Publishing in 2D Materials
- Vol. 11 (2) , 025009
Open AccessFive near-infrared-emissive graphene quantum dots for multiplex bioimaging
Due to high tissue penetration depth and low autofluorescence backgrounds, near-infrared (NIR) fluorescence imaging has recently become an advantageous diagnostic technique used in a variety of fields. However, most of the NIR fluorophores do not have therapeutic delivery capabilities, exhibit low photostabilities, and raise toxicity concerns. To address these issues, we developed and tested five types of biocompatible graphene quantum dots (GQDs) exhibiting spectrally-separated fluorescence in the NIR range of 928–1053 nm with NIR excitation. Their optical properties in the NIR are attributed to either rare-earth metal dopants (Ho-NGQDs, Yb-NGQDs, Nd-NGQDs) or defect-states (nitrogen doped GQDS (NGQDs), reduced graphene oxides) as verified by Hartree-Fock calculations. Moderate up to 1.34% quantum yields of these GQDs are well-compensated by their remarkable >4 h photostability. At the biocompatible concentrations of up to 0.5–2 mg ml−1 GQDs successfully internalize into HEK-293 cells and enable in vitro imaging in the visible and NIR. Tested all together in HEK-293 cells five GQD types enable simultaneous multiplex imaging in the NIR-I and NIR-II shown for the first time in this work for GQD platforms. Substantial photostability, spectrally-separated NIR emission, and high biocompatibility of five GQD types developed here suggest their promising potential in multianalyte testing and multiwavelength bioimaging of combination therapies.
- 28 August 2023
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2023-01 (9) , 1156
Automated Open-Loop in Vitro photothermal TherapyUsing Near-Infrared Emitting Graphene Quantum Dots
Graphene-based materials have been the subject of interest for photothermal therapy due to their high light to heat conversion efficiency. Graphene quantum dots (GQDs) are expected to both possess advantageous photothermal properties and facilitate visible and near-infrared (NIR) fluorescence image-tracking, while surpassing the other graphene-based materials in their biocompatibility. To test these capabilities several different GQD structures were synthesized using top-down (RGQDs from reduced graphene oxide) and bottom-up (HGQDs from molecular hyaluronic acid) approaches. RGQDs and HGQDs possess nanometer-scale sizes, are hydrophilic, and exhibit fluorescence throughout the visible and NIR. The high biocompatibility of RGQDs (1.5 mg/ml) and HGQDs (1.7 mg/ml) and substantial absorption tail in the NIR make them suitable for biological photothermal therapy applications. In aqueous suspensions of RGQDs and HGQDs, a low power (0.8 W/cm2) 808 nm NIR laser irradiation facilitates heating up to 46.0 and 47.0 °C, respectively, making them sufficient for cancer tumor ablation. In vitro photothermal studies were performed via cost-effective open-loop automated approach involving a 3D printer head controlling the laser and a thermocouple. These experiments are carried out in a 96 well plate to show that GQDs can facilitate HeLa cancer cells heating up to 54.5 and 43.5 °C from 37.0 °C, leading to the inhibition of cell viability down to 23%. GQDs’ fluorescence in the visible and NIR effectively tracks their intracellular accumulation verifying effects of photothermal treatment. The combination of therapeutic and imaging capabilities makes GQDs developed in this work highly prospective anticancer agents.
- 28 August 2023
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2023-01 (9) , 1156
Automated Open-Loop in Vitro photothermal TherapyUsing Near-Infrared Emitting Graphene Quantum Dots
Graphene-based materials have been the subject of interest for photothermal therapy due to their high light to heat conversion efficiency. Graphene quantum dots (GQDs) are expected to both possess advantageous photothermal properties and facilitate visible and near-infrared (NIR) fluorescence image-tracking, while surpassing the other graphene-based materials in their biocompatibility. To test these capabilities several different GQD structures were synthesized using top-down (RGQDs from reduced graphene oxide) and bottom-up (HGQDs from molecular hyaluronic acid) approaches. RGQDs and HGQDs possess nanometer-scale sizes, are hydrophilic, and exhibit fluorescence throughout the visible and NIR. The high biocompatibility of RGQDs (1.5 mg/ml) and HGQDs (1.7 mg/ml) and substantial absorption tail in the NIR make them suitable for biological photothermal therapy applications. In aqueous suspensions of RGQDs and HGQDs, a low power (0.8 W/cm2) 808 nm NIR laser irradiation facilitates heating up to 46.0 and 47.0 °C, respectively, making them sufficient for cancer tumor ablation. In vitro photothermal studies were performed via cost-effective open-loop automated approach involving a 3D printer head controlling the laser and a thermocouple. These experiments are carried out in a 96 well plate to show that GQDs can facilitate HeLa cancer cells heating up to 54.5 and 43.5 °C from 37.0 °C, leading to the inhibition of cell viability down to 23%. GQDs’ fluorescence in the visible and NIR effectively tracks their intracellular accumulation verifying effects of photothermal treatment. The combination of therapeutic and imaging capabilities makes GQDs developed in this work highly prospective anticancer agents.
- 28 August 2023
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2023-01 (9) , 1167
(Third Place Poster Award) Computational Assessment of the Optoelectronic Structure and Biomolecular Complexation of Graphene Quantum Dots
With novel materials getting smaller and their size falling to the nanometer scale, it becomes harder to fully characterize them by only using the experimental apparatus at hand. Therefore, taking advantage of computational methods proves to be trustworthy in filling those gaps and in aiding our experimental data to get a better understanding of the nanomaterials’ structural and electronic properties. Graphene quantum dots (GQDs) have recently become one of the flagships of carbon nanotechnology due to their remarkable physical properties and, when functionalized, an ability to become water soluble, biocompatible and capable of fluorescence in the visible and near-infrared. This makes them perspective carriers for therapeutic delivery and image-tracking. In order to assess the advantages of their utilization for a variety of bioapplications, we have investigated optical properties of doped GQDs and their interactions with biomolecules using a variety of molecular simulation approaches. True atomic ground state of the N-GQD is achieved via performing first-principle calculations based on density functional theory (DFT). DFT calculations also unrevealed the contributions of each functional group within the structure to HOMO–LUMO band edges. The adsorption of biomolecules and genes on the GQD surface has been further investigated with regards of the GQD structure, complementing experimental results that verify gene and drug complexation. Figure 1
- 28 August 2023
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2023-01 (9) , 1167
(Third Place Poster Award) Computational Assessment of the Optoelectronic Structure and Biomolecular Complexation of Graphene Quantum Dots
With novel materials getting smaller and their size falling to the nanometer scale, it becomes harder to fully characterize them by only using the experimental apparatus at hand. Therefore, taking advantage of computational methods proves to be trustworthy in filling those gaps and in aiding our experimental data to get a better understanding of the nanomaterials’ structural and electronic properties. Graphene quantum dots (GQDs) have recently become one of the flagships of carbon nanotechnology due to their remarkable physical properties and, when functionalized, an ability to become water soluble, biocompatible and capable of fluorescence in the visible and near-infrared. This makes them perspective carriers for therapeutic delivery and image-tracking. In order to assess the advantages of their utilization for a variety of bioapplications, we have investigated optical properties of doped GQDs and their interactions with biomolecules using a variety of molecular simulation approaches. True atomic ground state of the N-GQD is achieved via performing first-principle calculations based on density functional theory (DFT). DFT calculations also unrevealed the contributions of each functional group within the structure to HOMO–LUMO band edges. The adsorption of biomolecules and genes on the GQD surface has been further investigated with regards of the GQD structure, complementing experimental results that verify gene and drug complexation. Figure 1
- 28 August 2023
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2023-01 (9) , 1155
Graphene Quantum Dots for siRNA Delivery in Gene Silencing Cancer Therapy
Small interfering RNA (siRNA) technology in particular has become an advantageous tool in gene therapy for cancer treatment. However, the primary obstacle to this method is the inability of gene transfection of the cells on their own, their lack of stability in blood, and the lack of monitoring capabilities able to track gene delivery. Recently, graphene quantum dots (GQDs) have emerged as a platform allowing targeted drug delivery and fluorescence image-tracking in the visible and near-infrared regions. These capabilities can aid in overcoming obstacles to siRNA gene delivery. Here, for the first time, we have utilized biocompatible nitrogen and neodymium-doped graphene quantum dots (GQDs) for the delivery of Kirsten rat sarcoma virus (KRAS) and epidermal growth factor receptor (EGFR) siRNAs. The non-covalent loading of siRNA on GQDs was estimated by electrophoretic mobility shift assay and zeta potential. Successful siRNA delivery was confirmed by testing protein expression levels and using visible and near-infrared confocal fluorescence microscopy. The results show that GQDs/siRNA complex is biocompatible at the concentrations of 375-750 ug/mL and leads to protein knockdown in Hela cells at nanomolar siRNA concentrations. This shows the promising potential of GQDs for the delivery of siRNA and genes in general, complemented by multiwavelength image-tracking.
- 28 August 2023
- Published by The Electrochemical Society in ECS Meeting Abstracts
- Vol. MA2023-01 (9) , 1155
Graphene Quantum Dots for siRNA Delivery in Gene Silencing Cancer Therapy
Small interfering RNA (siRNA) technology in particular has become an advantageous tool in gene therapy for cancer treatment. However, the primary obstacle to this method is the inability of gene transfection of the cells on their own, their lack of stability in blood, and the lack of monitoring capabilities able to track gene delivery. Recently, graphene quantum dots (GQDs) have emerged as a platform allowing targeted drug delivery and fluorescence image-tracking in the visible and near-infrared regions. These capabilities can aid in overcoming obstacles to siRNA gene delivery. Here, for the first time, we have utilized biocompatible nitrogen and neodymium-doped graphene quantum dots (GQDs) for the delivery of Kirsten rat sarcoma virus (KRAS) and epidermal growth factor receptor (EGFR) siRNAs. The non-covalent loading of siRNA on GQDs was estimated by electrophoretic mobility shift assay and zeta potential. Successful siRNA delivery was confirmed by testing protein expression levels and using visible and near-infrared confocal fluorescence microscopy. The results show that GQDs/siRNA complex is biocompatible at the concentrations of 375-750 ug/mL and leads to protein knockdown in Hela cells at nanomolar siRNA concentrations. This shows the promising potential of GQDs for the delivery of siRNA and genes in general, complemented by multiwavelength image-tracking.